Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

PURPOSE: To evaluate prediction of response and event-free survival (EFS) following neoadjuvant endocrine therapy by SET2,3 index of nonproliferation gene expression related to estrogen and progesterone receptors adjusted for baseline prognosis.  EXPERIMENTAL DESIGN: A correlative study was conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Suman, Vera J., Du, Lili, Hoskin, Tanya, Anurag, Meenakshi, Ma, Cynthia, Bedrosian, Isabelle, Hunt, Kelly K., Ellis, Matthew J., Symmans, W. Fraser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357183/
https://www.ncbi.nlm.nih.gov/pubmed/35653124
http://dx.doi.org/10.1158/1078-0432.CCR-22-0068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357183/
https://www.ncbi.nlm.nih.gov/pubmed/35653124
http://dx.doi.org/10.1158/1078-0432.CCR-22-0068

Ejemplares similares